Assessing the role of long-term LHRH agonist (Eligard 45mg) in managing localised prostatic adenocarcinoma

Hdl Handle:
http://hdl.handle.net/10147/190069
Title:
Assessing the role of long-term LHRH agonist (Eligard 45mg) in managing localised prostatic adenocarcinoma
Authors:
Rangaswamy, G; Ibrahim, N; Thirion, P
Affiliation:
Deparment of Radiation Oncology, St. Luke's Hospital, Dublin 6.
Citation:
2011, 45 (41) : 48 Irish Medical Times
Issue Date:
Oct-2011
URI:
http://hdl.handle.net/10147/190069
Item Type:
Article; Other
Language:
en
Description:
A team from the Radiation Oncology Department at St. Luke's Hospital, Dublin, present a case of high risk localised adenocarcinoma of the prostate and discuss the role of leuprorelin acetate (Eligard) in the management of a case
Keywords:
PROSTATE CANCER

Full metadata record

DC FieldValue Language
dc.contributor.authorRangaswamy, Gen
dc.contributor.authorIbrahim, Nen
dc.contributor.authorThirion, Pen
dc.date.accessioned2011-11-21T08:46:54Z-
dc.date.available2011-11-21T08:46:54Z-
dc.date.issued2011-10-
dc.identifier.citation2011, 45 (41) : 48 Irish Medical Timesen
dc.identifier.urihttp://hdl.handle.net/10147/190069-
dc.descriptionA team from the Radiation Oncology Department at St. Luke's Hospital, Dublin, present a case of high risk localised adenocarcinoma of the prostate and discuss the role of leuprorelin acetate (Eligard) in the management of a caseen
dc.language.isoenen
dc.subjectPROSTATE CANCERen
dc.titleAssessing the role of long-term LHRH agonist (Eligard 45mg) in managing localised prostatic adenocarcinomaen
dc.typeArticleen
dc.typeOtheren
dc.contributor.departmentDeparment of Radiation Oncology, St. Luke's Hospital, Dublin 6.en
All Items in Lenus, The Irish Health Repository are protected by copyright, with all rights reserved, unless otherwise indicated.